Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Current Deferred Revenue (2020 - 2025)

908 Devices (MASS) has disclosed Current Deferred Revenue for 6 consecutive years, with $8.9 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 14.24% to $8.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Dec 2025, down 14.24% year-over-year, with the annual reading at $8.9 million for FY2025, 14.24% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $8.9 million at 908 Devices, down from $18.3 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $22.5 million in Q3 2024, with the low at $8.9 million in Q4 2025.
  • Average Current Deferred Revenue over 5 years is $15.8 million, with a median of $16.4 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue soared 373.11% in 2021, then crashed 39.1% in 2024.
  • Over 5 years, Current Deferred Revenue stood at $14.5 million in 2021, then rose by 13.7% to $16.5 million in 2022, then grew by 3.6% to $17.1 million in 2023, then tumbled by 39.1% to $10.4 million in 2024, then fell by 14.24% to $8.9 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $8.9 million, $18.3 million, and $18.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.